Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Teva Pharma Industries Ltd ADR (TEVA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Teva ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.86 +0.07    +0.59%
19/04 - Closed. Currency in USD ( Disclaimer )
After Hours
12.94
+0.08
+0.62%
0:00:00 - Real-time Data
  • Volume: 9,742,232
  • Bid/Ask: 12.75 / 12.95
  • Day's Range: 12.51 - 13.01
Type:  Equity
Market:  United States
Teva ADR 12.86 +0.07 +0.59%

TEVA Recent Sentiments

 
User's sentiments regarding Teva ADR shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect TEVA shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Teva ADR.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 19, 2024 בעז bnbh   12.87 +0.08%
Apr 18, 2024 Doronn Victor   12.79 -0.55%
Apr 18, 2024 ללו חורש   12.79 +0.55%
Apr 18, 2024 Baruch Zaltsberg   13.18 -2.43%
Apr 17, 2024 מומי כהן   13.12 -1.98%
Apr 17, 2024 Влад Григоров   13.22 -2.72%
Apr 17, 2024 Chonnapan Thanadchang   13.26 -3.02%
Apr 16, 2024 Matan Fridman   13.17 -2.35%
Apr 16, 2024 חיים כהן   13.15 +2.21%
Apr 16, 2024 דורון שוקרון   13.11 -1.91%
Apr 16, 2024 מיכאל גרינוולד   13.13 +2.06%
Apr 16, 2024 אבי פלד   13.20 -2.58%
Apr 15, 2024 אביאל אביאל   13.20 -2.58%
Apr 15, 2024 Mati Almo   13.21 +2.65%
Apr 15, 2024 שמואל טוטיאן   13.32 -3.45%
Apr 15, 2024 אייל עובדיה   13.40 -4.03%
Apr 15, 2024 reuven bumandil   13.39 Apr 15, 2024 @ 13.38 -0.07%
Apr 15, 2024 Lukas Hajek   13.39 Apr 15, 2024 @ 13.38 +0.07%
Apr 12, 2024 שייקה פרסתאי   13.26 -3.02%
Apr 12, 2024 טיבי וייס   13.15 -2.21%
Apr 12, 2024 REUVEN KARGER   13.16 Apr 15, 2024 @ 13.38 +1.67%
Apr 12, 2024 Venancio Litico   13.10 -1.83%
Apr 12, 2024 משה לביא   13.22 -2.72%
Apr 12, 2024 Mati Almo   13.41 Apr 15, 2024 @ 13.38 +0.22%
Apr 12, 2024 Chonnapan Thanadchang   13.53 Apr 15, 2024 @ 13.38 -1.11%
Apr 12, 2024 ליעד שרבליס   13.88 Apr 15, 2024 @ 13.38 -3.60%
Apr 11, 2024 שמואל טוטיאן   13.84 Apr 15, 2024 @ 13.38 -3.32%
Apr 11, 2024 Jaromir Lhotka   13.81 -6.88%
Apr 11, 2024 Albert Farfoory   13.80 Apr 15, 2024 @ 13.38 -3.04%
Apr 11, 2024 Marina Rimon   13.73 Apr 15, 2024 @ 13.38 -2.55%
Apr 09, 2024 דרור שונים   13.84 -7.08%
Apr 09, 2024 אסף סנ   13.79 -6.74%
Apr 09, 2024 guy damari   13.91 -7.55%
Apr 09, 2024 Rajeev Gupta   14.34 Apr 15, 2024 @ 13.38 -6.69%
Apr 09, 2024 alfonso garcia   14.00 Apr 15, 2024 @ 13.38 -4.43%
Apr 08, 2024 יוסי אלצטר   14.18 +9.31%
Apr 08, 2024 Elyor Mahkamov   14.26 -9.82%
Apr 08, 2024 שמעיה אמינוב   14.24 Apr 15, 2024 @ 13.38 -6.04%
Apr 05, 2024 ויצמן ארבל   14.26 -9.82%
Apr 05, 2024 נעם שניר   14.29 -10.01%
Apr 05, 2024 ניסים עזרא   14.12 -8.92%
Apr 05, 2024 Ofer Moshe   13.89 Apr 08, 2024 @ 14.27 -2.74%
Apr 04, 2024 רפאל טייב   14.21 -9.50%
Apr 04, 2024 אלי אליהו   14.19 Apr 08, 2024 @ 14.27 +0.56%
Apr 04, 2024 משה פדידה   14.12 Apr 08, 2024 @ 14.27 +1.06%
Apr 04, 2024 ללו חורש   14.03 Apr 08, 2024 @ 14.27 +1.71%
Apr 04, 2024 צביקה קגנסקי   14.05 -8.47%
Apr 03, 2024 יאיר פרטוש   14.11 -8.86%
Apr 03, 2024 Hhvt Bvvg   14.03 Apr 08, 2024 @ 14.27 +1.71%
Apr 03, 2024 שמואל טוטיאן   14.03 Apr 08, 2024 @ 14.27 +1.71%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Price Commentary

Write your thoughts about Teva Pharma Industries Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rafi Shoev
Rafi Shoev Jan 22, 2024 23:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva 125years of developing new drugs bigest jeneic company andto be leader in biosimilar drugs.
Rafi Shoev
Rafi Shoev Jan 17, 2024 14:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva free cash flew aoutsyrnding
Rafi Shoev
Rafi Shoev Jan 16, 2024 15:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
24.02.24 Alboteck and teva .Humira biosimilar on the top of the day.from FDA.finally.
Rafi Shoev
Rafi Shoev Jan 16, 2024 15:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Freecash is very intresting???
Rafi Shoev
Rafi Shoev Jan 16, 2024 15:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very atractiv ???
Rafi Shoev
Rafi Shoev Jan 15, 2024 10:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva revenew my hope will be more than 17.5bilions.
Rafi Shoev
Rafi Shoev Jan 12, 2024 19:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If your stock is dawn its probably a time to by more.
Rafi Shoev
Rafi Shoev Jan 12, 2024 16:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Concidering to sturting by back .
Rafi Shoev
Rafi Shoev Jan 12, 2024 15:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The humira biosomilar wil be agaim changer
Rafi Shoev
Rafi Shoev Jan 12, 2024 14:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
jaint phrma is nomber one in tell aviv stock.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email